FHIR IG analytics
| Package | hl7.fhir.uv.xver-r4.r3 |
| Resource Type | ValueSet |
| Id | ValueSet-R4-research-study-phase-for-R3.json |
| FHIR Version | R3 |
| Source | http://hl7.org/fhir/uv/xver-r4.r3/0.1.0/ValueSet-R4-research-study-phase-for-R3.html |
| URL | http://hl7.org/fhir/uv/xver/ValueSet/R4-research-study-phase-for-R3 |
| Version | 0.1.0 |
| Status | active |
| Date | 2026-03-17T21:02:03.8104715+00:00 |
| Name | R4ResearchStudyPhaseForR3 |
| Title | Cross-version ValueSet R4.ResearchStudyPhase for use in FHIR STU3 |
| Realm | uv |
| Authority | hl7 |
| Description | This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/research-study-phase|4.0.1` for use in FHIR STU3. |
| Purpose | This value set is part of the cross-version definitions generated to enable use of the
value set `http://hl7.org/fhir/ValueSet/research-study-phase|4.0.1` as defined in FHIR R4
in FHIR STU3.
The source value set is bound to the following FHIR R4 elements:
* `ResearchStudy.phase`
Note that all concepts are included in this cross-version definition because no concepts have compatible representations
Following are the generation technical comments:
FHIR ValueSet `http://hl7.org/fhir/ValueSet/research-study-phase|4.0.1`, defined in FHIR R4 does not have any mapping to FHIR STU3 |
Resources that use this resource
| StructureDefinition |
| hl7.fhir.uv.xver-r4.r3#0.1.0 | extension-ResearchStudy.phase | R4: n-a | early-phase-1 | phase-1 | phase-1-phase-2 | phase-2 | phase-2-phase-3 | phase-3 | phase-4 (new) |
Resources that this resource uses
Narrative
Note: links and images are rebased to the (stated) source
This value set expansion contains 8 concepts.
| System | Version | Code | Display | Definition |
http://terminology.hl7.org/CodeSystem/research-study-phase | 4.0.1 | early-phase-1 | Early Phase 1 | Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0. |
http://terminology.hl7.org/CodeSystem/research-study-phase | 4.0.1 | n-a | N/A | Trials without phases (for example, studies of devices or behavioral interventions). |
http://terminology.hl7.org/CodeSystem/research-study-phase | 4.0.1 | phase-1 | Phase 1 | Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients. |
http://terminology.hl7.org/CodeSystem/research-study-phase | 4.0.1 | phase-1-phase-2 | Phase 1/Phase 2 | Trials that are a combination of phases 1 and 2. |
http://terminology.hl7.org/CodeSystem/research-study-phase | 4.0.1 | phase-2 | Phase 2 | Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks. |
http://terminology.hl7.org/CodeSystem/research-study-phase | 4.0.1 | phase-2-phase-3 | Phase 2/Phase 3 | Trials that are a combination of phases 2 and 3. |
http://terminology.hl7.org/CodeSystem/research-study-phase | 4.0.1 | phase-3 | Phase 3 | Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug. |
http://terminology.hl7.org/CodeSystem/research-study-phase | 4.0.1 | phase-4 | Phase 4 | Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use. |
Source1
{
"resourceType": "ValueSet",
"id": "R4-research-study-phase-for-R3",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 1
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "brr"
},
{
"extension": [
{
"url": "packageId",
"valueId": "hl7.fhir.uv.xver-r4.r3"
},
{
"url": "version",
"valueString": "0.1.0"
},
{
"url": "uri",
"valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r4.r3"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use",
"_valueCode": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r4.r3"
}
]
}
}
],
"url": "http://hl7.org/fhir/uv/xver/ValueSet/R4-research-study-phase-for-R3",
"version": "0.1.0",
"name": "R4ResearchStudyPhaseForR3",
"title": "Cross-version ValueSet R4.ResearchStudyPhase for use in FHIR STU3",
"status": "active",
"experimental": false,
"date": "2026-03-17T21:02:03.8104715+00:00",
"publisher": "Biomedical Research and Regulation",
"contact": [
{
"name": "Biomedical Research and Regulation",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/rcrim"
}
]
}
],
"description": "This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/research-study-phase|4.0.1` for use in FHIR STU3.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001",
"display": "World"
}
]
}
],
"purpose": "This value set is part of the cross-version definitions generated to enable use of the\r\nvalue set `http://hl7.org/fhir/ValueSet/research-study-phase|4.0.1` as defined in FHIR R4\r\nin FHIR STU3.\r\n\r\nThe source value set is bound to the following FHIR R4 elements:\r\n* `ResearchStudy.phase`\r\n\r\nNote that all concepts are included in this cross-version definition because no concepts have compatible representations\r\n\r\nFollowing are the generation technical comments:\r\n\nFHIR ValueSet `http://hl7.org/fhir/ValueSet/research-study-phase|4.0.1`, defined in FHIR R4 does not have any mapping to FHIR STU3",
"compose": {
"include": [
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"concept": [
{
"code": "early-phase-1",
"display": "Early Phase 1"
},
{
"code": "n-a",
"display": "N/A"
},
{
"code": "phase-1",
"display": "Phase 1"
},
{
"code": "phase-1-phase-2",
"display": "Phase 1/Phase 2"
},
{
"code": "phase-2",
"display": "Phase 2"
},
{
"code": "phase-2-phase-3",
"display": "Phase 2/Phase 3"
},
{
"code": "phase-3",
"display": "Phase 3"
},
{
"code": "phase-4",
"display": "Phase 4"
}
]
}
]
},
"expansion": {
"timestamp": "2026-03-17T21:02:03.8104715+00:00",
"contains": [
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "early-phase-1",
"display": "Early Phase 1"
},
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "n-a",
"display": "N/A"
},
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "phase-1",
"display": "Phase 1"
},
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "phase-1-phase-2",
"display": "Phase 1/Phase 2"
},
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "phase-2",
"display": "Phase 2"
},
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "phase-2-phase-3",
"display": "Phase 2/Phase 3"
},
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "phase-3",
"display": "Phase 3"
},
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "phase-4",
"display": "Phase 4"
}
]
}
}
FHIR
FHIRsmith